Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data

详细信息    查看全文

• 作者：Shardul Paricharak ; Adriaan P. IJzerman ; Andreas Bender ; Florian Nigsch
• 刊名：ACS Chemical Biology
• 出版年：2016
• 出版时间：May 20, 2016
• 年：2016
• 卷：11
• 期：5
• 页码：1255-1264
• 全文大小：608K
• 年卷期：0
• ISSN：1554-8937

文摘

With increased automation and larger compound collections, the development of high-throughput screening (HTS) started replacing previous approaches in drug discovery from around the 1980s onward. However, even today it is not always appropriate, or even feasible, to screen large collections of compounds in a particular assay. Here, we present an efficient method for iterative screening of small subsets of compound libraries. With this method, the retrieval of active compounds is optimized using their structural information and biological activity fingerprints. We validated this approach retrospectively on 34 Novartis in-house HTS assays covering a wide range of assay biology, including cell proliferation, antibacterial activity, gene expression, and phosphorylation. This method was employed to retrieve subsets of compounds for screening, where selected hits from any given round of screening were used as starting points to select chemically and biologically similar compounds for the next iteration. By only screening ∼1% of the full screening collection (∼15 000 compounds), the method consistently retrieves diverse compounds belonging to the top 0.5% of the most active compounds for the HTS campaign. For most of the assays, over half of the compounds selected by the method were found to be among the 5% most active compounds of the corresponding full-deck HTS. In addition, the stringency of the iterative method can be modified depending on the number of compounds one can afford to screen, making it a flexible tool to discover active compounds efficiently.